AI assistant
Revenio Group Oyj — Director's Dealing 2022
Feb 17, 2022
3236_rns_2022-02-17_5a69831a-99c4-477f-ad0a-e9bf96756328.pdf
Director's Dealing
Open in viewerOpens in your device viewer
REVENIO
Revenio Group Corporation: Managers' Transactions - Karvo Tomi
Revenio Group Corporation Managers' transactions February 17, 2022 at 4.30 p.m. (EET)
Revenio Group Oyj - Managers' Transactions
Person subject to the notification requirement
Name: Tomi Karvo
Position: Other senior manager
Issuer: Revenio Group Oyj
LEI: 743700127E0FWSXLKK04
Notification type: INITIAL NOTIFICATION
Reference number: 10129/4/4
Transaction date: 2022-02-14
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: F10009010912
Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE
Transaction details
(1): Volume: 1865 Unit price:
Aggregated transactions
(1): Volume: 1865 Volume weighted average price:
For further information, please contact:
CFO Robin Pulkkinen, tel. +358 50 505 9932
www.revenio.fi
DISTRIBUTION:
Nasdaq Helsinki Ltd
Main media
www.revenio.fi
Revenio Group in brief
Revenio is a leading company in the global market for ophthalmological devices and software solutions. Revenio's ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), perimeter and fundus imaging devices under the iCare brand. In addition, the Group's eye care software platform Oculo offers clinical communication, telehealth, remote patient monitoring and data analytics capabilities.
Revenio Group
Àyritie 22
FI-01510 Vantaa
REVENIO
In 2021, the Group's net sales totaled EUR 78.8 million, with an operating profit of EUR 22.1 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.
Attachments
Revenio Group Corporation: Managers' Transactions – Karvo Tomi
Revenio Group | Äyritie 22 | FI-01510 Vantaa